Kiora Pharmaceuticals, Inc.

KPRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$5,509$1,028$3,771$3,792
Short-Term Investments$13,867$19,638$20,335$23,000
Receivables$1,213$3,114$2,060$601
Inventory$0$0$0$0
Other Curr. Assets$2,105$957$942$2,313
Total Curr. Assets$22,694$24,737$27,107$29,706
Property Plant & Equip (Net)$420$456$157$62
Goodwill$0$0$0$0
Intangibles$6,687$6,687$6,687$0
Long-Term Investments$0$4$0$0
Tax Assets$0$0$0$0
Other NC Assets$63$61$68$6,716
Total NC Assets$7,170$7,208$6,913$6,778
Other Assets$0$0$0$0
Total Assets$29,863$31,946$34,020$36,484
Liabilities
Payables$241$283$942$416
Short-Term Debt$156$143$72$23
Tax Payable$0$0$2,457$0
Deferred Revenue$0$1,250$0$0
Other Curr. Liab.$2,183$1,510$1,804$5,570
Total Curr. Liab.$2,580$3,186$5,275$6,009
LT Debt$248$287$87$34
Deferred Rev, NC$0$1,250$0$0
Deferred Tax Liab, NC$0$491$491$0
Other NC Liab.$4,624$4,604$4,467$4,682
Total NC Liab.$4,872$6,632$5,045$4,716
Other Liabilities$0$0$0$0
Cap. Leases$404$430$159$57
Total Liabilities$7,453$9,818$10,319$10,725
Equity
Pref Stock$0$0$0$0
Common Stock$272$272$268$268
Retained Earnings-$147,701-$147,728-$145,575-$143,382
AOCI-$244-$246-$297-$282
Other Equity$170,083$169,829$169,305$169,156
Total Equity$22,411$22,127$23,700$25,760
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$29,863$31,946$34,020$36,484
Net Debt-$5,105-$598-$3,612-$3,735